Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc is positioned favorably in the expanding market for pandemic-related antibody treatments, projected to reach $3-4 billion globally by 2030, with its innovative products incorporating advanced half-life extension technology and biophysical characteristics suggesting best-in-class potential. The company’s VBY329 candidate showcases impressive antiviral potency and superior neutralization capabilities against resistant variants, indicating a strong competitive edge in addressing evolving viral threats. Encouraging Phase 1/2 safety data contributes to high confidence in the long-term utility of these therapies, reinforcing the company’s prospects for future regulatory and commercial success.

Bears say

Invivyd Inc. is centered on developing antibody-based therapies aimed at enhancing protection against infectious diseases like COVID-19; however, the company grapples with challenges regarding the broader acceptance and utility of its products within a competitive market. Emphasis on the limitations of existing vaccines, including concerns over waning efficacy and public hesitancy, further compounds the difficulty in securing a favorable position in the evolving landscape of viral interventions. Additionally, while the projected 2024 COVID vaccine revenue of approximately $4 billion highlights a significant total addressable market, it underscores the intense competition and the potential risk associated with reliance on an environment characterized by diminishing vaccine effectiveness.

Invivyd Inc (IVVD) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.